Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.

Touizer E., Alrubayyi A., Rees-Spear C., Fisher-Pearson N., Griffith SA., Muir L., Pellegrino P., Waters L., Burns F., Kinloch S., Rowland-Jones S., Gupta RK., Gilson R., Peppa D., McCoy LE.

DOI

10.1016/s2352-3018(21)00099-0

Type

Journal article

Journal

The lancet. HIV

Publication Date

06/2021

Volume

8

Pages

e317 - e318

Addresses

Division of Infection and Immunity, University College London, London WC1E 6BT, UK.

Keywords

CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes, Humans, HIV-1, HIV Infections, Adenine, RNA, Viral, CD4 Lymphocyte Count, CD4-CD8 Ratio, Neutralization Tests, Treatment Failure, Antiretroviral Therapy, Highly Active, Adult, Emtricitabine, Heterocyclic Compounds, 4 or More Rings, COVID-19, SARS-CoV-2, COVID-19 Vaccines

Permalink Original publication